The University of Arizona
Map Home
Loading...
Adjust height of sidebar
KMap

Grant

A First In Human Multicenter, Open-Label Study to Determine the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ABBV-319 in B-cell Malignancies

Sponsored by AbbVie Incorporated

Active
$2.1M Funding
3 People
External

Related Topics

People